Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exer Labs is a private digital health and healthcare AI company developing computer-vision-based clinical software for musculoskeletal and movement assessment. Its platform uses smartphone and tablet cameras to measure motion, range of motion, gait, tremor, and related functional metrics without requiring wearables or dedicated sensors. The company markets products including Exer Health, Exer Gait, Exer Physio, and Exer Scan for use across orthopedic, rehabilitation, neurology, senior care, and hybrid care workflows. Exer appears to operate commercially with provider-focused software and regulated device products rather than a traditional therapeutic drug pipeline. The business is based in Denver and has positioned itself as a motion-intelligence platform for precision care in musculoskeletal and movement disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Exer Labs.